How to Buy Penumbra Stock
Penumbra Inc
Penumbra is a medical device company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker PEN on the NYSE exchange.
Penumbra stock last closed at $325.18, up 0.44% from the previous day, and has increased 29.36% in one year. It has overperformed other stocks in the Medical Devices industry by 1.29 percentage points. Penumbra stock is currently +46.97% from its 52-week low of $221.26, and -10.27% from its 52-week high of $362.41.
As of Aug 21, 2026, there are 39.39M shares of PEN outstanding. The market capitalization of PEN is $12.81B. In the last 24 hours, 167,000 PEN shares were traded.
How to Buy Penumbra Stock
Wondering how to invest in Penumbra stock? Here's how.
- Decide where to buy Penumbra stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Penumbra stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Select your payment method and add your info.
- Research Penumbra stock: The Penumbra ticker symbol is PEN. Is Penumbra stock a good investment? Should you buy shares of PEN? How do PEN's underlying business fundamentals look? Do top analysts think Penumbra is a good buy? Why has PEN's stock price moved recently? (Hint: Our stock research tools can help you figure out if PEN is a good stock to buy).
- Execute your PEN buy order: Decide if you will purchase PEN shares at the current market price or use a limit order to buy PEN shares at a specific price.
- Get the latest news on your PEN position: Create a watchlist to important notifications about your position in Penumbra stock.
Step 1: Decide where to buy Penumbra stock
You will need a brokerage account to access the NYSE market and buy PEN stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can buy PEN stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create your new trading account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have created your account on a investment app, you can securely and quickly fund your account:
Check out the video below to see the process of transferring funds into your brokerage account.
Step 4: Research Penumbra stock
After you have chosen the best place to buy Penumbra stock, it's crucial to evaluate their stock before you buy, so you actually wrap your head around the risk and opportunity.
Penumbra shares at a glance
Penumbra Due Diligence Score
WallStreetZen was built to help part-time investors do better fundamental analysis in less time.
You can view all of the due diligence checks on PEN's stock page.
Is PEN stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PEN's intrinsic value.
Using relative valuations metrics:
- PEN may be overvalued based on its P/E ratio of 79.51x, relative to Medical Devices industry P/E ratio of 24.5x
- PEN could be overvalued based on its P/B ratio of 8.37x, relative to Medical Devices industry P/B ratio of 3.39x
- PEN could be overvalued based on its PEG ratio of 3.4x
You can do more valuation research on PEN's stock here.
PEN Financial Health
Signs that PEN is financially healthy:
- PEN earnings of $203.83M is not sufficient to cover its interest payments.
- PEN has a low debt to equity ratio of 0.29.
- There are more short-term assets than short-term liabilities on the PEN balance sheet.
- Total PEN debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the PEN balance sheet.
- PEN's operating cash flow of $277.80M allows it to safely service it's debt of $212.71M.
Signs that PEN is not financially healthy:
- PEN profit margin has gone down from 11.5% to 10.7% in the past year.
Do Wall Street analysts think it's a good time to buy PEN stock
Out of 3 Equities analysts who give ratings on PEN, the consensus analyst rating on Penumbra is a Hold
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Penumbra stock forecast page.
PEN Technicals
PEN Performance Metrics
Last year, PEN earnings were $160.59M. Over the past 5 year, PEN's earnings have increased by 56.91% per year. This was faster than the Medical Devices industry average of 12.03%.
Last year, PEN revenue was $1.50B. During the last 5 year, PEN's revenue has grown by 17.52% per year. This was faster than the Medical Devices industry average of 8.75%.
You can analyze PEN's earnings and revenue performance here.
Who is buying/selling PEN?
In the last year, executives and large shareholders at PEN have sold more shares than they have bought.
Harpreet Grewal, Director of PEN, was the latest PEN insider to sell. They sold $32,822.00 worth of PEN shares on Apr 2, 2026.
Research more about who owns PEN stock here.
Does PEN provide a stable income stream?
No, Penumbra doesn't provide an income stream by paying out dividends.
What do other traders have to say about PEN?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your PEN buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your PEN position
Now that you own some shares in PEN, you'll want to stay up-to-date on your investment.
Add PEN to a watchlist to keep tabs on your PEN stock.
PEN Feed
How to Buy Stock in Penumbra
To summarize, here are the 6 steps to buy stock in Penumbra:
- Decide where to buy Penumbra stock
- Sign up for a brokerage account
- Put funds into your investment account
- Research Penumbra stock
- Execute your PEN buy order
- Get the latest news on your PEN position
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Penumbra, hit the button below to create your watchlist.
More Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.